Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World Study

Small-airway disease (SAD) is a key feature of severe asthma and is associated with poor symptom control and frequent exacerbations. Dupilumab has demonstrated efficacy in improving lung function and reducing exacerbations, but real-world evidence on its effects in SAD remains limited. The aim of th...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Lorenzo Carriera, Angelo Coppola, Roberto Lipsi, Stefano Baglioni, Pier-Valerio Mari, Roberto Barone, Simone Ielo, Raffaele Scala, Andrea Smargiassi, Riccardo Inchingolo, Luca Richeldi, Valeria Gambacorta, Alfredo Di Giovanni, Eugenio De Corso
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-02-01
Cyfres:	Advances in Respiratory Medicine
Pynciau:	asthma small airways small-airway disease impulse oscillometry dupilumab
Mynediad Ar-lein:	https://www.mdpi.com/2543-6031/94/2/14
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!